×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TEVA – teva pharmaceutical industries limited american depositary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TEVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/30
09:55 am
teva
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]
Low
Report
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]
3/30
08:00 am
teva
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
Low
Report
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
3/30
05:45 am
teva
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
Low
Report
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
3/19
04:45 pm
teva
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]
Low
Report
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]
3/19
04:30 pm
teva
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
Medium
Report
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
3/19
04:30 pm
teva
Teva Releases Q1 2026 Aide Memoire
Medium
Report
Teva Releases Q1 2026 Aide Memoire
3/15
08:05 pm
teva
Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its 75% One Year Rally? [Yahoo! Finance]
Medium
Report
Is It Too Late To Reassess Teva Pharmaceutical Industries (TEVA) After Its 75% One Year Rally? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
1/28/2026
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
BEAT
Report
4.4%
teva pharmaceutical industries limited american depositary shares
11/5/2025
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
BEAT
Report
9.9%
teva pharmaceutical industries limited american depositary shares
7/30/2025
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
BEAT
Report
0.4%
teva pharmaceutical industries limited american depositary shares
5/7/2025
07:00 am
teva
teva pharmaceutical industries limited american depositary shares
BEAT
Report
5.3%
teva pharmaceutical industries limited american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
04:01 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 17 Filed by: Sabag Mark
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 17 Filed by: Sabag Mark
3/17
04:15 pm
teva
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Sabag Mark
Low
Report
Form 144 TEVA PHARMACEUTICAL INDU Filed by: Sabag Mark
3/9
04:23 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Sabag Mark
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Sabag Mark
3/9
04:22 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Kalif Eliyahu Sharon
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Kalif Eliyahu Sharon
3/9
04:20 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Weiss Amir
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Weiss Amir
3/9
04:18 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Francis Richard D
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Francis Richard D
3/9
04:17 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Fox Christine
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Fox Christine
3/9
04:15 pm
teva
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Hughes Eric A
Low
Report
Form 4 TEVA PHARMACEUTICAL INDU For: Mar 05 Filed by: Hughes Eric A
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
10/18
Shortage of critical children’s cancer drug causes concerns nationwide [MSNBC.com]
16.9%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
8/7 Dow Takes a Sharp Dive as Treasury Yields Tumble [TheStreet.com] 13.9%
2/12 New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion 10.7%
11/7 Form 10-Q TEVA PHARMACEUTICAL INDU For: Sep 30 10.5%
10/16 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was upgraded by analysts at Gabelli from a "hold" rating to a "buy" rating. 10.4%
1/13 Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 38th Annual JP Morgan Healthcare Conference (Transcript) [Seeking Alpha] 9.7%
2/3 Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan 7.7%
9/6 Purdue Pharma in talks to settle DOJ opioid probes - WSJ [Seeking Alpha] 7.2%
6/24 UPDATE 2-Oklahoma judge approves Teva's $85 million opioid settlement [Reuters (UK)] 7.0%
11/26 U.S. prosecutors open criminal probe of opioid makers, distributors [Reuters (UK)] 6.7%
TOP News Decliners
5/11
U.S. states sue Teva, 19 other drug companies in price-fixing complaint [Reuters (UK)]
-14.7%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
5/28 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. -13.8%
3/12 Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®? (fremanezumab) -13.5%
8/6 Earnings Outlook: Teva Pharmaceuticals reports earnings on Wednesday. Here’s what to expect [MarketWatch] -11.2%
3/19 Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide -10.2%
11/25 Form 8-K TEVA PHARMACEUTICAL INDU For: Nov 25 -8.0%
5/30 Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was downgraded by analysts at Bank of America Corp from a "buy" rating to an "underperform" rating. -6.9%
4/21 QuestCap Appoints Douglas Sommerville as President of MedQuest Investment Division [Canadian Business Journal (Canada)] -6.9%
10/7 Teva to Host Conference Call to Discuss Third Quarter 2019 Financial Results at 8 a.m. ET on November 7, 2019 -6.4%
11/6 Form 4 TEVA PHARMACEUTICAL INDU For: Nov 05 Filed by: McClellan Michael James -6.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: